• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国东南部泰州 HPV33 E6 和 E7 基因变异与宫颈癌发病风险的关联。

Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China.

机构信息

Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, 317000, Zhejiang, China.

Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, Zhejiang, China.

出版信息

Virol J. 2023 Jul 19;20(1):156. doi: 10.1186/s12985-023-02125-9.

DOI:10.1186/s12985-023-02125-9
PMID:37468974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10354908/
Abstract

BACKGROUND

Human papillomavirus (HPV) 33 belongs to the Alphapapillomavirus 9 (α-9 HPV) species group, which also contains types 16, 31, 35, 52, 58 and 67. The purpose of this study was to investigate the genetic variations of HPV33 and to explore its carcinogenicity among women in Taizhou, Southeast China.

METHODS

Exfoliated cervical cells were collected for HPV genotyping. Only single HPV33 infection cases were selected, and their E6 and E7 genes were sequenced using the ABI 3730xl sequencer and then analysed using MEGA X.

RESULTS

From 2014 to 2020, a total of 185 single HPV33-positive specimens were successfully amplified. We obtained 15 distinct HPV33 E6/E7 variants, which were published in GenBank under accession numbers OQ672665-OQ672679. Phylogenetic analysis revealed that all HPV33 E6/E7 variants belonged to lineage A, of which 75.7% belonged to lineage A1. Compared with CIN1, the proportion of sublineage A1 in CIN2/3 was higher, but there was no significant difference (76.5% vs. 80.6%, P > 0.05). Altogether, 20 single nucleotide substitutions were identified, of which 6 were novel substitutions, including T196G (C30G), A447T, G458T (R117L), G531A, A704A, and C740T. In addition, no significant trends were observed between the nucleotide substitutions of HPV33 E6/E7 variants and the risk of cervical lesions.

CONCLUSION

This study provides the most comprehensive data on genetic variations, phylogenetics and carcinogenicity of HPV33 E6/E7 variants in Southeast China to date. The data confirmed that cervical lesions among women in Taizhou are attributable to HPV33, which may be due to the high infection rate of sublineage A1 in the population.

摘要

背景

人乳头瘤病毒(HPV)33 属于阿尔法乳多空病毒 9(α-9 HPV)种组,该组还包含 16、31、35、52、58 和 67 型。本研究旨在调查 HPV33 的遗传变异,并探讨其在中国东南部台州地区女性中的致癌性。

方法

收集宫颈脱落细胞进行 HPV 基因分型。仅选择单纯 HPV33 感染病例,使用 ABI 3730xl 测序仪对其 E6 和 E7 基因进行测序,并使用 MEGA X 进行分析。

结果

2014 年至 2020 年,共成功扩增了 185 例单纯 HPV33 阳性标本。我们获得了 15 种不同的 HPV33 E6/E7 变体,这些变体已在 GenBank 中以 OQ672665-OQ672679 的登录号发表。系统进化分析表明,所有 HPV33 E6/E7 变体均属于谱系 A,其中 75.7%属于谱系 A1。与 CIN1 相比,CIN2/3 中小谱系 A1 的比例更高,但差异无统计学意义(76.5%比 80.6%,P>0.05)。共发现 20 个单核苷酸替换,其中 6 个为新的替换,包括 T196G(C30G)、A447T、G458T(R117L)、G531A、A704A 和 C740T。此外,HPV33 E6/E7 变体的核苷酸替换与宫颈病变的风险之间没有明显的趋势。

结论

本研究提供了迄今为止中国东南部 HPV33 E6/E7 变体遗传变异、系统发育和致癌性最全面的数据。数据证实,台州地区女性的宫颈病变归因于 HPV33,这可能是由于该人群中 A1 亚谱系的高感染率所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63b2/10354908/44e756b58e48/12985_2023_2125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63b2/10354908/0f19330d2050/12985_2023_2125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63b2/10354908/44e756b58e48/12985_2023_2125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63b2/10354908/0f19330d2050/12985_2023_2125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63b2/10354908/44e756b58e48/12985_2023_2125_Fig2_HTML.jpg

相似文献

1
Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China.中国东南部泰州 HPV33 E6 和 E7 基因变异与宫颈癌发病风险的关联。
Virol J. 2023 Jul 19;20(1):156. doi: 10.1186/s12985-023-02125-9.
2
Genetic variability and oncogenic risk association of human papillomavirus type 58 E6 and E7 genes in Taizhou area, China.中国泰州地区人乳头瘤病毒 58 型 E6 和 E7 基因的遗传变异性与致癌风险关联。
Gene. 2019 Feb 20;686:171-176. doi: 10.1016/j.gene.2018.11.066. Epub 2018 Nov 22.
3
Phylogenetic analysis and antigenic epitope prediction for E6 and E7 of Alpha-papillomavirus 9 in Taizhou, China.中国泰州α-乳头瘤病毒 9 的 E6 和 E7 的系统进化分析和抗原表位预测。
BMC Genomics. 2024 May 22;25(1):507. doi: 10.1186/s12864-024-10411-1.
4
Genetic variability of E6 and E7 genes of human papillomavirus type 58 in Jingzhou, Hubei Province of central China.中国中部湖北省荆州市人乳头瘤病毒 58 型 E6 和 E7 基因的遗传变异。
Virol J. 2022 Apr 22;19(1):71. doi: 10.1186/s12985-022-01801-6.
5
Genetic variation of E6, E7, and L1 genes of human papillomavirus 51 from central China.中国中部地区人乳头瘤病毒 51 型 E6、E7 和 L1 基因的遗传变异。
J Med Virol. 2022 Jun;94(6):2811-2823. doi: 10.1002/jmv.27603. Epub 2022 Jan 31.
6
Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.辽宁省宫颈病变妇女中 HPV58 型 E6、E7、L1 基因和长控制区的变异。
Infect Genet Evol. 2012 Oct;12(7):1466-72. doi: 10.1016/j.meegid.2012.05.004. Epub 2012 May 29.
7
Genetic variation of E6 and E7 genes of human papillomavirus 52 from Central China.中国中部地区人乳头瘤病毒 52 型 E6 和 E7 基因的遗传变异。
J Med Virol. 2021 Jun;93(6):3849-3856. doi: 10.1002/jmv.26690. Epub 2020 Dec 1.
8
Genetic variability in the E6 and E7 oncogenes of HPV52 and its prevalence in the Taizhou area, China.HPV52 型 E6 和 E7 致癌基因的遗传变异性及其在中国泰州地区的流行率。
Virol J. 2022 Nov 22;19(1):194. doi: 10.1186/s12985-022-01929-5.
9
Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.中国台州地区人乳头瘤病毒(HPV)18基因变异与宫颈癌风险
Gene. 2018 Mar 20;647:192-197. doi: 10.1016/j.gene.2018.01.037. Epub 2018 Jan 10.
10
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China.中国泰州地区 HPV16 E6 和 E7 变异与宫颈癌发病风险的关联。
BMC Cancer. 2021 Jul 3;21(1):769. doi: 10.1186/s12885-021-08531-y.

引用本文的文献

1
Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 33.人乳头瘤病毒33型的检出率、基因多态性、病毒载量、持续感染能力及致病性研究
Virol J. 2025 Apr 26;22(1):121. doi: 10.1186/s12985-025-02752-4.
2
Lineage analysis of human papillomavirus types 33 and 35 based on E6 gene in cervical samples from Tehran, Iran.基于E6基因对伊朗德黑兰宫颈样本中33型和35型人乳头瘤病毒的谱系分析
Sci Rep. 2025 Apr 21;15(1):13736. doi: 10.1038/s41598-025-97080-6.
3
Cervical HPV infection and related diseases among 149,559 women in Fujian: an epidemiological study from 2018 to 2023.

本文引用的文献

1
Could HPV Type 33 Be More Risky Than We Thought?HPV 型 33 比我们想象的更危险?
Int J Surg Pathol. 2023 Feb;31(1):4-10. doi: 10.1177/10668969221134692. Epub 2022 Dec 5.
2
Genetic variability in the E6 and E7 oncogenes of HPV52 and its prevalence in the Taizhou area, China.HPV52 型 E6 和 E7 致癌基因的遗传变异性及其在中国泰州地区的流行率。
Virol J. 2022 Nov 22;19(1):194. doi: 10.1186/s12985-022-01929-5.
3
The polymorphism analysis and epitope predicted of Alphapapillomavirus 9 E6 in Sichuan, China.中国四川地区的 Alphapapillomavirus 9 E6 多态性分析与表位预测。
福建149,559名女性的宫颈人乳头瘤病毒感染及相关疾病:一项2018年至2023年的流行病学研究
Front Microbiol. 2024 Jun 19;15:1418218. doi: 10.3389/fmicb.2024.1418218. eCollection 2024.
4
Phylogenetic analysis and antigenic epitope prediction for E6 and E7 of Alpha-papillomavirus 9 in Taizhou, China.中国泰州α-乳头瘤病毒 9 的 E6 和 E7 的系统进化分析和抗原表位预测。
BMC Genomics. 2024 May 22;25(1):507. doi: 10.1186/s12864-024-10411-1.
Virol J. 2022 Jan 20;19(1):14. doi: 10.1186/s12985-021-01728-4.
4
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China.中国泰州地区 HPV16 E6 和 E7 变异与宫颈癌发病风险的关联。
BMC Cancer. 2021 Jul 3;21(1):769. doi: 10.1186/s12885-021-08531-y.
5
Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.在中国西南部鉴定 HPV-33/HPV-58 E6 和 E7 中的变体和治疗性表位。
Virol J. 2019 May 28;16(1):72. doi: 10.1186/s12985-019-1168-y.
6
Prevalence of oncogenic Human papillomavirus and genetic diversity in the L1 gene of HPV16 HPV 18 HPV31 and HPV33 found in women from Vojvodina Province Serbia.在塞尔维亚伏伊伏丁那省女性中发现的致癌性人乳头瘤病毒的流行情况以及HPV16、HPV18、HPV31和HPV33的L1基因的遗传多样性。
Biologicals. 2019 Mar;58:57-63. doi: 10.1016/j.biologicals.2019.02.001. Epub 2019 Feb 20.
7
Cervical cancer.宫颈癌。
Lancet. 2019 Jan 12;393(10167):169-182. doi: 10.1016/S0140-6736(18)32470-X.
8
Genetic variability and oncogenic risk association of human papillomavirus type 58 E6 and E7 genes in Taizhou area, China.中国泰州地区人乳头瘤病毒 58 型 E6 和 E7 基因的遗传变异性与致癌风险关联。
Gene. 2019 Feb 20;686:171-176. doi: 10.1016/j.gene.2018.11.066. Epub 2018 Nov 22.
9
Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases.人乳头瘤病毒在10575例浸润性宫颈癌神经内分泌肿瘤中的作用
Papillomavirus Res. 2018 Jun;5:134-142. doi: 10.1016/j.pvr.2018.03.005. Epub 2018 Mar 17.
10
Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.中国台州地区人乳头瘤病毒(HPV)18基因变异与宫颈癌风险
Gene. 2018 Mar 20;647:192-197. doi: 10.1016/j.gene.2018.01.037. Epub 2018 Jan 10.